Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:43 PM
Ignite Modification Date:
2025-12-24 @ 7:43 PM
NCT ID:
NCT00001203
Eligibility Criteria:
* INCLUSION CRITERIA
Patients studied under this protocol will be at risk for or have evidence of significant excess tissue iron.
Most patients will be on regular blood transfusion secondary to either congenital or acquired anemia.
The majority of patients have homozygous beta thalassemia.
Patients with sickle cell anemia will be included only when there is an absolute indication for regular blood transfusions (e.g., a history of stroke).
Twenty to thirty adults with acquired anemia and good long-term prognosis will be accepted for study if chelation can be initiated early in their transfusion history (less than 30-50 units).
EXCLUSION CRITERIA
Such patients will be excluded from study if they have diabetes or cardiac disease due to another cause (coronary artery or valvular heart disease).
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
4 Years
Study:
NCT00001203
Study Brief:
Protocol Section:
NCT00001203